Director, Market Access & Operations at Legend Biotech

Franklin Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor's degree required; advanced degree preferred
Extensive knowledge of the US pharmaceutical & biotech market; experience in oncology
Extensive knowledge of the US market access landscape
Minimum of 10 years of pharma marketing, sales or access experience
Ability to work effectively with and through others; cross-functional leadership
Comfort with MS Office
Knowledge of core LEGEND systems and processes

Responsibilities

Work closely with the J&J Access team partners to find opportunities, implement existing tactics and achieve access goals
Lead Legend payer and key customer market access research initiatives
Support development of the value story for CARVYKTI
Support development of the annual strategic business plan for US
Develop field-level data tools and analytic capabilities to enhance local business planning and execution effectiveness
Provide practical field and business guidance on critical projects
Lead a number of critical business projects – landscape assessment, evolving trends, channel mix implications, etc
Help translate the voice of the customer into actionable strategies, ensuring that commercial efforts align with market demands as well as customer preferences and requirements
Lead multiple projects simultaneously, oversee project timelines, resources, and budgets to deliver successful outcomes
Spearhead new initiatives on behalf of the team to support the general upskilling of the organization
Perform an active role in brainstorming sessions with the cross-functional LT
Drive decision making related to project execution, including timelines, milestones and resource allocation within budget (higher-level approvals required for significant budget allocations, strategic shifts, or major collaborations with substantial financial or long-term implications)

Skills

Market Access

Pricing Strategy

Payer Research

Value Story Development

Strategic Planning

Data Analytics

Stakeholder Management

Biotech Commercialization

Field Data Tools

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free